Intraventricular Dyssynchrony Predicts Mortality and Morbidity After Cardiac Resynchronization Therapy A Study Using Cardiovascular Magnetic Resonance Tissue Synchronization Imaging by Chalil, Shajil et al.
T
a
c
3
h
p
s
p
c
F
B
C
f
I
D
2
Journal of the American College of Cardiology Vol. 50, No. 3, 2007
© 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00
PCardiac Resynchronization Therapy
Intraventricular Dyssynchrony Predicts Mortality and
Morbidity After Cardiac Resynchronization Therapy
A Study Using Cardiovascular Magnetic
Resonance Tissue Synchronization Imaging
Shajil Chalil, MRCP,* Berthold Stegemann, PHD,† Sarkaw Muhyaldeen, MRCP,*
Kayvan Khadjooi, MRCP,* Russell E. A. Smith, MD, FRCP,* Paul J. Jordan, FRCP,*
Francisco Leyva, MD, FRCP*
Birmingham, England; and Maastricht, the Netherlands
Objectives We aimed to assess a novel measure of left ventricular (LV) dyssynchrony, a cardiovascular magnetic resonance-
tissue synchronization index (CMR-TSI), in patients with heart failure (HF). A further aim was to determine whether
CMR-TSI predicts mortality and major cardiovascular events (MCE) after cardiac resynchronization therapy (CRT).
Background Cardiac dyssynchrony is a predictor of mortality in patients with HF. The unparalleled spatial resolution of CMR
may render CMR-TSI a predictor of clinical benefit after CRT.
Methods In substudy A, CMR-TSI was assessed in 66 patients with HF (age 60.8  10.8 years, LV ejection fraction 23.9 
12.1% [mean  SD]) and 20 age-matched control subjects. In substudy B, CMR-TSI was assessed in relation to
clinical events in 77 patients with HF and with a QRS 120 ms undergoing CRT.
Results In analysis A, CMR-TSI was higher in patients with HF and a QRS 120 ms (79.5  31.2 ms, p  0.0003) and
in those with a QRS 120 ms (105.9  55.8 ms, p  0.0001) than in control subjects (21.2  8.1 ms). In anal-
ysis B, a CMR-TSI 110 ms emerged as an independent predictor of the composite end points of death or un-
planned hospitalization for MCE (hazard ratio [HR] 2.45; 95% confidence interval [CI] 1.51 to 4.34, p  0.0002)
or death from any cause or unplanned hospitalization for HF (HR 2.15; 95% CI 1.23 to 4.14, p  0.0060) as
well as death from any cause (HR: 2.6; 95% CI 1.29 to 6.73, p  0.0061) and cardiovascular death (HR 3.82;
95% CI 1.63 to 16.5, p  0.0007) over a mean follow-up of 764 days.
Conclusions Myocardial dyssynchrony assessed by CMR-TSI is a powerful independent predictor of mortality and morbidity
after CRT. (J Am Coll Cardiol 2007;50:243–52) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.03.035p
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nhe benefits of cardiac resynchronization therapy (CRT)
re well established. In the CARE-HF (Cardiac Resyn-
hronization Heart Failure) study, CRT was associated with
6% reduction in all-cause mortality (1). It is well accepted,
owever, that the prognostic benefit of CRT in individual
atients is difficult to predict from pre-implant assessments,
uch as echocardiography.
Studies using tissue Doppler imaging have shown that, in
atients with heart failure (HF), intraventricular dyssyn-
hrony is associated with a higher rate of cardiac decom-
rom the *Department of Cardiology, Good Hope Hospital, Sutton Coldfield/
irmingham, West Midlands, England; and †Medtronic Inc., Bakken Research
enter, Maastricht, the Netherlands. Drs. Chalil and Muhyaldeen held research
ellowships sponsored by Medtronic Inc. Dr. Stegemann is an employee of Medtronic
nc. Drs. Smith, Jordan, and Leyva have received sponsorship from Medtronic Inc.
r. Leyva has also received sponsorship from St. Jude Medical.y
Manuscript received November 20, 2006; revised manuscript received March 9,
007, accepted March 13, 2007.ensation (2). In patients with hypertrophic cardiomyopa-
hy, intraventricular dyssynchrony is an independent
redictor of sudden cardiac death (3). With regard to
atients undergoing CRT, numerous studies have focused
n echocardiographic predictors of reverse left ventricular
LV) remodeling and/or symptoms (4,5), but few have
xplored cardiac dyssynchrony in relation to mortality.
In the assessment of cardiac dyssynchrony, echocardiog-
aphy is limited to imaging only a portion of the LV. In
ontrast, cardiovascular magnetic resonance (CMR) allows
maging of the entire heart. In this study, a novel technique
or assessing cardiac dyssynchrony, CMR-tissue resynchro-
ization imaging, was developed using short-axis views of
he LV. Segmental radial wall motion data were used to
onstruct tissue synchronization polar maps of the LV and
o derive a global dyssynchrony measure, the tissue synchro-
ization index (CMR-TSI). This study comprised 2 anal-
ses: in the first, the CMR-TSI was assessed in healthy
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CRT and CMR July 17, 2007:243–52subjects and in patients with HF;
in the second, the CMR-TSI was
assessed in relation to mortality as
well as hospitalizations, LV re-
modeling, functional capacity, and
quality of life in patients with HF
undergoing CRT.
Methods
This study consisted of 2 sub-
studies, both of which entailed
quantification of LV volumes,
LV ejection fraction (LVEF),
and CMR-TSI.
Substudy 1. In this substudy,
the measurements as described in
the preceding text were studied
in relation to QRS duration in 66
consecutive patients with HF in
New York Heart Association
(NYHA) functional class III or
IV and with an LVEF 35%.
The etiology was coronary heart
isease in 53 patients and dilated cardiomyopathy in 13.
hese were compared with 20 age-matched, healthy control
ubjects with a QRS duration 120 ms.
ubstudy 2. The aim of this substudy was to determine the
bility of the CMR-TSI to predict cardiovascular death,
eath from any cause, major cardiovascular events (MCE),
nd HF admissions in 77 patients with HF and a QRS
120 ms undergoing CRT. This group included 42 pa-
ients from substudy 1.
Patients in substudy 2 also underwent a 6-min hall walk
est (6), a quality-of-life assessment using Minnesota Living
ith Heart Failure questionnaire (7), and transthoracic
chocardiography on the day before implantation, at 1, 3,
nd 6 months thereafter. Follow-up data on patients who
ied relates to the last available review before death.
evice therapy. All patients in substudy 2 underwent
ransvenous biventricular pacemaker implantation using
tandard techniques under local anesthesia. Patients were
ntered into the study only after a successful implantation
nd were followed-up in a dedicated CRT clinic. None of
he patients in atrial fibrillation underwent atrioventricular
ode ablation. Patients in sinus rhythm (n 68) underwent
ransmitral Doppler-directed optimization of atrioventricu-
ar delay (8) before discharge and at every scheduled visit
hereafter. Backup atrial pacing was set at 60 beats/min, and
he pacing mode was set to DDDR with an interventricular
elay of 4 ms. For patients in chronic atrial fibrillation (n 
), right ventricular and LV leads were implanted, and a
edtronic InSync III generator (model 8042, Medtronic,
inneapolis, Minnesota) was used, plugging the atrial port
nd programming the generator to a ventricular triggered
Abbreviations
and Acronyms
CMR-TSI  cardiovascular
magnetic resonance-tissue
synchronization index
CRT  cardiac
resynchronization therapy
HF  heart failure
LV  left ventricle/
ventricular
LVEDV  left ventricular
end-diastolic volume
LVEF  left ventricular
ejection fraction
LVESV  left ventricular
end-systolic volume
MCE  major
cardiovascular events
NYHA  New York Heart
Association
ROC  receiver-operating
characteristicode. Generators used included the Medtronic InSync III codel 8040 8042 (n  61), St. Jude Frontier (St. Jude
edical, St. Paul, Minnesota) (n  2), Vitatron CRT 8000
Vitatron B.V., Arnhem, the Netherlands) (n  2),
iotronik Stratos (Biotronik GmbH, Berlin, Germany)
n  8), and Guidant Contak Renewal TR2 (Guidant
orp., St. Paul, Minnesota) (n  4).
MR. Images were acquired on a 1.5-T (General Electric
igna, GE Healthcare Worldwide, Slough, United King-
om) scanner using a phased-array cardiac coil during
epeated 8-s breathholds. A short-axis stack of LV images
as acquired using a steady-state in free precession sequence
repetition time 3.0 to 3.8 ms; excitation time 1.0 ms; image
atrix 224  224; field of view 36 to 42 cm; flip angle 45o)
n sequential 8-mm slices (2-mm interslice gap) from the
trioventricular ring to apex. Left ventricular volumes,
jection fraction, and mass (myocardial density  1.05
/cm3) were quantified using manual planimetry of all
hort-axis steady state free precession cine images with
ASS analysis software (Medis, Leiden, the Netherlands).
ach slice in the short-axis stack (Fig. 1A) was divided into
00 cords, running clockwise from a first cord located at the
unction between the inferior right ventricular free wall and
he interventricular septum. Radial wall motion was quan-
ified semiautomatically for all cords at up to 20 phases
time points) in each R-R interval. This yielded up to
6,000 raw data points per patient (100 cords for each of 8
lices imaged over 20 phases. Radial wall motion data were
btained for each of 6 segments (Fig. 1B) in each of,
ypically, 8 slices, for 20 phases (time points). The observer
as blinded to all other clinical details of the patients,
ncluding the outcome measures.
SI. The maximum radial wall motion value of a segmen-
al radial wall motion time series was chosen to parameterize
he peak radial wall motion for each segment for this
nalysis. The time-dependent segmental radial wall motion
ata (y) were fitted to an empirical sine wave function y 
 b * sin (t/RR  c). The sine wave function was chosen
o account for the cyclic nature of myocardial motion and to
pecifically obtain the main cyclic radial wall motion com-
onent from the radial wall motion data. The mean seg-
ental radial wall motion (a), the cyclic segmental radial
all motion amplitude (b), and the segmental phase shift of
he maximum radial wall motion (c) were extracted from the
t. The CMR-TSI was finally calculated as the standard
eviation (SD) of all segmental phase shift of the radial wall
otion extracted from the fit.
chocardiography. Standard 2-dimensional echocardiog-
aphy was performed using System 5 (GE Healthcare
orldwide). Standard left parasternal long-axis and short-
xis, and apical, 4-, 5-, and 2-chamber views were obtained.
igital images were transferred to a computer (EchoPAC,
E Healthcare Worldwide) for off-line analysis. Left ven-
ricular volumes were assessed using planimetry of apical
-chamber views and Simpson’s equation. The LVEF was
alculated as follows: (left ventricular end-diastolic volume
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July 17, 2007:243–52 CRT and CMRLVEDV]  left ventricular end-systolic volume [LVESV])/
VEDV  100%.
ollow-up and end points. After pacemaker implantation,
atients were followed up in a dedicated CRT clinic. As in
he CARE-HF study (1), the clinical end points considered
ere the composite of death from any cause or an un-
lanned hospitalization for a MCE, which included cardiac
ransplantation. Hospitalizations for worsening HF, myo-
ardial infarction, unstable angina, arrhythmia, stroke, pul-
onary embolism, or upgrading to an implantable
ardioverter-defibrillator were included in this end point.
he first event was included in the analysis. The second end
oint considered was the composite of death from any cause
nd unplanned hospitalization with worsening HF. The
hird end point considered was mortality from any cause.
he additional end point of cardiovascular mortality was
lso considered. Sudden cardiac death was defined as “a
atural, unexpected death due to cardiac causes, heralded by
Figure 1 Myocardial Wall Motion in a Control Subject and in a
(A) Division of the left ventricular (LV) myocardium into slices and segments. (B) T
delimits the beginning of segment 1 and the end of segment 6, counting clockwis
cardiac cycle in an LV basal slice in a control subject (C) and in a patient with hean abrupt loss of consciousness within one hour of the onset uf acute symptoms” (9). Mortality data were collected
hrough medical records and, where appropriate, from
nterviews with patients’ caregivers. Information regarding
linical outcome was collected by an investigator who was
linded to the results of the CMR study.
tatistical analysis. Continuous variables are expressed as
ean  SD. Normality was tested using the Shapiro-Wilk
est (the W-statistic). Variables that were not normally
istributed were log-transformed before statistical analyses.
omparisons between normally distributed continuous vari-
bles were made using analysis of variance (ANOVA) with
cheffe’s F procedure for multiple comparisons. Categorical
ariables were analyzed using chi-square tests and Fisher
xact post-hoc test. Changes in variables from baseline to
ollow-up were analyzed using repeated measures ANOVA.
ariables showing significant group differences at baseline
ere entered into Cox proportional hazards analyses.
Receiver-operating characteristic (ROC) curves were
nt With Heart Failure
ction between the interventricular septum and the right ventricular (RV) free wall
nd D) Representative graph of radial wall motion of LV segments throughout the
re (HF) and a left bundle branch block (LBBB) (D).Patie
he jun
e. (C a
rt failused to derive optimal cutoff points for CMR-TSI. For the
d
H
o
d
m
C
1
d
a
h
e
u
w
S
w
m
r
s
v
b
246 Chalil et al. JACC Vol. 50, No. 3, 2007
CRT and CMR July 17, 2007:243–52ifferentiation between control subjects and patients with
F in substudy 1, the value of CMR-TSI with the
ptimum sensitivity and specificity was 40 ms. For the
ifferentiation between the groups at the highest risk of
eeting the various end points in substudy 2, the value of
MR-TSI with the optimum sensitivity and specificity was
10 ms for all end points. The ability of CMR-TSI to
iscriminate between patients in the various risk categories
t this cutoff value was assessed using Cox proportional
azards analyses and Kaplan-Meier survival curves. Differ-
nces in survival curves between the groups were assessed
sing the log-rank (Mantel-Cox) test. Statistical analyses
ere performed using Statview (Cary, North Carolina) and
PSS 13.0 (Chicago, Illinois). A 2-tailed p value of 0.05
as considered statistically significant.
Intraobserver variability of CMR-TSI was derived from
anual planimetry of short-axis stacks from CMR of 10
andomly selected subjects. Studies were performed by the
ame observer on 2 occasions 11 months apart. Interobserver
ariability was derived from the same subjects, performed by 2
Figure 2 CMR-TSI Polar Color Maps in a Healthy Control Subje
Note the late contraction of the inferoposterior wall in the patient with heart failure
branch block (LBBB). CMR-TSI  cardiovascular magnetic resonance tissue synchrct and in a Patient With Heart Failure and an LBBB
and a left bundle
onization index.linded observers. Both intra- and interobserver variabilitiesFigure 3 Intraventricular Dyssynchrony in
Control Subjects and in Patients With HF
Box and whisker plot for CMR-TSI in 20 healthy control subjects with a QRS
120 ms and in 66 patients with heart failure, grouped according to QRS
120 ms, QRS 120 to 149 ms, and QRS 150 ms. The 5 horizontal lines
represent the 10th, 25th, 50th, 75th, and 90th percentiles, from bottom to
top. CMR-TSI  cardiovascular magnetic resonance tissue synchronization
index; HF  heart failure.
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July 17, 2007:243–52 CRT and CMRere calculated as the SD of the absolute differences between
he 2 measurements divided by the mean of both measure-
ents, and expressed as a percentage. Intraobserver and inter-
bserver variability for CMR-TSI was 3.01% and 8.84%,
espectively. Intraobserver and interobserver correlations were
.99 and 0.98, respectively. In Bland Altman analyses, the
ntraobserver and interobserver agreements, expressed in terms
f the mean difference  2 SD (upper and lower limits of
greement), were 1.16 (2.04 to 4.36) and 1.25 (6.92 to 9.41),
espectively.
Analysis of wall motion was performed using the R
tatistical language (10). The nonlinear least square fit
unction implemented by Bates and DebRoy into the “nls”
acket of R was used for the sine fit (11).
aseline Clinical and Cardiovascular Magnetic Resonance Imagingor Pati nts Undergoing Cardiac Resynchronization Therapy, Groupe
Table 1 Baseline Clinical and Cardiovascular Magnetic Resonafor Patients Undergoing Cardiac Resynchronization The
All
n 77
Follow-up period, days† 764 (379)
Age, yrs 67.3 9.8
Gender, male (%) 58 (75)
Etiology, n (%)
Coronary heart disease 58 (75)
Dilated cardiomyopathy 19 (25)
Systolic blood pressure, mm Hg 118.3 20.0
Diastolic blood pressure, mm Hg 70.1 11.2
Comorbidity
Diabetes mellitus 9 (12)
Hypertension 20 (26)
CABG 20 (26)
Valve replacement 1 (0.01)
Medication, n (%)
Loop diuretics 68 (88)
ACE-I or ARB 70 (91)
Beta-blockers 43 (56)
Spironolactone 37 (48)
Amiodarone 10 (13)
ECG variables
Sinus rhythm 68 (88)
Atrial fibrillation 9 (12)
QRS duration, ms 150.3 25.1
CMR variables
LVEDV, cm3 237.8 93.4
LVESV, cm3 191.9 92.2
LVEF, % 22.6 11.5
CMR-TSI, ms 112.6 53.2
Mode of death
Pump failure 10
Sudden cardiac death 2
End points
Death from any cause or hospitalization for MCE 26 (34)
Death from any cause or hospitalization for HF 19 (25)
Death from any cause 15 (19)
Cardiovascular death 14 (18)
Refers to differences between the cardiovascular magnetic resonance tissue synchronization in
ontinuous variables are expressed as mean  SD.
ACE-I angiotensin-converting enzyme inhibitors; ARB angiotensin II receptor blockers; CABG coro
nd-diastolic volume; LVEF  left ventricular ejection fraction; LVESV  left ventricular end-systolic volumesults
ubstudy 1. Patients with HF (n  66, age 60.8  10.8
ears) had an LVEF of 23.9  12.1% and a QRS duration of
47.8  25.0 ms. As shown in Figure 1C, the pattern of wall
otion was relatively homogenous in healthy control subjects,
ut heterogenous in patients with HF. The heterogeneity of
adial wall motion in patients with HF was also apparent in
olor polar maps of CMR-TSI (Fig. 2). The more homoge-
ous distribution of color in the sine fit polar maps compared
ith the absolute value of the time-to-peak wall motion is a
eflection of the smoothing effect of the sine fit.
The CMR-TSI was higher in patients with HF and a
RS 120 ms (79.5  31.2 ms, p  0.0003), in patients
acteristics and Clinical End Pointscording to Degree of Dyssynchrony
maging Characteristics and Clinical End Points
, Grouped According to Degree of Dyssynchrony
CMR-TSI <110 ms CMR-TSI >110 ms p Value*
43 34
763 (368) 765 (398) NS
68.5 10.2 66.4 9.6 NS
31 (72) 27 (79) NS
28 (65) 30 (88) 0.0195
15 (35) 4 (12) 0.0195
119.3 22.2 117.3 18.8 NS
70.1 11.6 70.1 11.1 NS
3 (7) 6 (18) NS
12 (28) 8 (24) NS
9 (21) 11 (32) NS
0 1 (3) NS
38 (88) 30 (88) NS
39 (91) 31 (91) NS
23 (53) 20 (59) NS
22 (51) 15 (44) NS
5 (12) 5 (15) NS
37 (86) 31 (91) NS
6 (14) 3 (9) NS
145.1 21.4 157.0 28.0 0.0372
203.8 69.4 282.6 102.9 0.0002
158.0 72.1 236.8 97.6 0.0002
26.6 13.0 17.2 5.9 0.0004
78.4 21.6 154.7 50.3 0.0001
0 10 0.0001
1 1 NS
5 (12) 21 (62) 0.0001
4 (9) 15 (44) 0.0004
2 (5) 12 (35) 0.0004
1 (2) 13 (38) 0.0001
MR-TSI) 110 group and the CMR-TSI 110 ms group; †Refers to follow-up period for events.Chard Ac
nce I
rapy
dex (Cnary artery bypass grafting; ECG electrocardiogram; HF heart failure; LVEDV left ventricular
e; MCE  major adverse cardiac events.
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CRT and CMR July 17, 2007:243–52ith HF and a QRS between 120 and 149 ms (98.5  36.2
s, p 0.0001), and in patients with HF and a QRS150
s (112.1  68.7 ms, p  0.0001) than in control subjects
21.2  8.1 ms) (Fig. 3). At a cutoff of 40 ms, CMR-TSI
chieved almost absolute discrimination between control
ubjects and patients with HF (area under ROC 0.99,
ensitivity 94%, specificity of 100%, p  0.0001), a reflec-
ion of the lack of overlap in CMR-TSI between the groups.
ubstudy 2. As shown in Table 1, patients with a CMR-
SI 110 ms had a longer QRS duration (p  0.0372),
igher LVEDV and LVESV (both p  0.0002), and a
ower LVEF (p  0.0004) than patients with a CMR-TSI
110 ms. In the 77 patients undergoing CRT, CMR-TSI
t baseline correlated positively with LVEDV (r  0.46),
VESV (r 0.49), and negatively with LVEF (r0.55)
all p  0.0001). There was a positive correlation between
RS duration and CMR-TSI (r  0.46, p  0.0001).
Over a mean follow-up of 764 days (range 85 to 1,602
ays), patients with a CMR-TSI 110 ms were 5.2 times
ore likely to die from any cause or to be hospitalized for a
CE, 11 times more likely die from any cause or to be
ospitalized for HF, 7 times more likely to die from any
ause, and 19 times more likely to suffer a cardiovascular
eath than those with a CMR-TSI 110 ms.
Over a mean of 557 days (range 59 to 1,144 days) to the
atest available clinical review, significant reductions in
YHA functional class as well as improvements in 6-min
alk test distance and quality-of-life scores were observed in
oth the CMR-TSI110 ms and the CMR-TSI110 ms
roups (Table 2). An increase in LVEF was observed in the
MR-TSI 110 ms group (p  0.01), but not in the
MR-TSI 110 ms group. A reduction in LVESV was
bserved in the CMR-TSI110 ms group, but this was not
tatistically significant (p  0.0986).
As shown in Figure 4, the area under ROCs relating to
he ability of CMR-TSI to discriminate between patients
eeting the various end points ranged from 0.75 to 0.82. At
Clinical and Echocardiographic Variables Duringardiac Resynchronization Therapy, Grouped Acat Baselin
Table 2
Clinical and Echocardiographic Vari
Cardiac Resynchronization Therapy,
at Baseline
CMR-TSI <
(n  4
Baseline
NYHA functional class, n (%)
I 0
II 0
III 29 (67)
IV 14 (33)
6-min walk test, m 273.6 106.2
Quality-of-life score 61.7 18.1
Echocardiography
LVESV, cm3 150.7 60.3
LVEDV, cm3 197.3 62.0
LVEF, % 26.5 12.0*p  0.0001; †p  0.001; ‡p  0.01. p values refer to differences from bas
NYHA  New York Heart Association; other abbreviations as in Table 1.cutoff of 110 ms, CMR-TSI predicted cardiovascular
eath with a sensitivity of 93% and a specificity of 67% (p
.0001). Kaplan-Meier survival curves showed that the rates
f meeting the various end points were higher in the
MR-TSI 110 ms group than in the CMR-TSI 110
s group (Fig. 5). In Cox proportional hazards analyses,
MR-TSI emerged as a strong predictor of all clinical end
oints, independent of LVEDV, LVESV, LVEF, and QRS
uration (Table 3).
An additional analysis using QRS duration as a dichoto-
ous variable, either between 120 ms and 149 ms (n 31) or
150 ms (n 46), no group differences emerged with respect
o the composite of death from any cause or an unplanned
ospitalization for an MCE (9 and 17 patients, respectively),
he composite of death from any cause and unplanned hospi-
alization with worsening HF (8 and 11 patients, respectively),
eath from any cause (6 and 9 patients, respectively), or
ardiovascular death (6 and 8 patients, respectively). When
RS duration as a dichotomized variable was entered into Cox
roportional hazards analyses for each of the end points, it
ailed to reach statistical significance (data not shown).
iscussion
e have shown that, on the basis of CMR-TSI, a novel
easure of LV dyssynchrony, almost all patients with HF
ave LV dyssynchrony. The most salient finding from this
tudy is that in patients undergoing CRT, CMR-TSI
redicts death from any cause, cardiovascular mortality, as
ell as the combined end points of death from any cause or
ospitalizations for an MCE, and death from any cause or
ospitalization from HF.
yssynchrony as a predictor of mortality and morbid-
ty. Our finding that increasing LV dyssynchrony, quanti-
ed using the CMR-TSI, predicts survival and morbidity
ight be expected from our observation that LV dyssyn-
hrony correlates positively with LV volumes, and nega-
w-Up in Patients Undergoingng to Degree of Dyssynchrony
During Follow-Up in Patients Undergoing
ped According to Degree of Dyssynchrony
s CMR-TSI >110 ms
(n  34)
ollow-Up Baseline Follow-Up
2 (28)* 0 6 (18)*
1 (49)* 0 19 (56)*
8 (19)* 28 (82) 9 (26)*
2 (5)* 6 (18) 0*
1 122.2* 254.2 99.8 326.1 97.8†
2 25.8* 47.1 18.3 29.0 21.0†
1 58.1 170.0 58.8 163.1 49.2
8 60.5 221.8 57.9 209.7 53.4
8 12.1‡ 24.1 10.3 24.4 0.09Follocordi
ables
Grou
110 m
3)
F
1
2
355.
28.
136.
190.
31.eline values within the group.
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July 17, 2007:243–52 CRT and CMRively with LVEF. It would appear, therefore, that dyssyn-
hrony is a marker of poor cardiac function and the patients
ith the most dyssynchronous, dilated, and poorly function-
ng LVs are the least likely to respond to CRT, measured in
erms of mortality and hospital readmissions. At a cutoff of
10 ms, CMR-TSI predicted cardiovascular death with a
ensitivity of 93% and a specificity of 67% (p  0.0001).
Numerous echocardiographic studies have shown that LV
yssynchrony is a predictor of improvement in LV function
nd reverse LV remodeling after CRT (12–14). Bax et al. (14),
owever, found that LV dyssynchrony correlated positively
ith reductions in LVESV after CRT, but up to a limit.
eyond a septal-to-posterior wall motion delay of 100 ms,
RT did not result in reductions in LVESV. In the present
tudy, we have not observed evidence of LV remodeling after
RT. However, an improvement in LVEF was witnessed in
he CMR-TSI110 ms, but not in the CMR-TSI110 ms
Figure 4 Receiver-Operating Characteristic Curves for CMR-TSI
AUC  area under the curve; MCE  major cardiovascular events; sens  sensitivroup. This lack of improvement in LVEF was paralleled by a tarked increase in the risk of death or hospitalizations for both
CE and HF. A possible interpretation of this finding is that
here is an upper limit of dyssynchrony beyond which CRT
ails to confer a benefit.
Intuitively, patients who die or who are repeatedly hospital-
zed for HF after CRT would also be expected to be the
ymptomatic nonresponders. In the present study, patients
ith a CMR-TSI 110 ms were at higher risk of death and
eadmissions for MCE and HF than those with a CMR-TSI
110 ms, but improvements in NYHA functional class, 6-min
alk test, and quality-of-life scores up to the last available
ollow-up were nevertheless significant. This is in keeping with
he demonstration that clinical improvement after CRT is not
ecessarily a predictor of survival (15). It is also in keeping with
he finding of a lack of correlation between clinical and
chocardiographic changes after CRT (16).
yssynchrony in HF. Echocardiographic studies using
elation to Clinical End Points
ec  specificity; other abbreviations as in Figure 3.in R
ity; spissue Doppler imaging have shown evidence of LV dyssyn-
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CRT and CMR July 17, 2007:243–52hrony only in a proportion of patients with HF (17). Using
he SD of the time to peak systolic velocity in a 12
yocardial segment model as a measure of dyssynchrony,
u et al. (17) demonstrated systolic dyssynchrony in only
4% of patients with HF and a QRS duration 120 ms. In
he present study, however, nearly all patients with HF had
V dyssynchrony, defined in terms of a CMR-TSIs 40
s. It would appear, therefore, that, at least on the basis of
MR-TSI, HF is synonymous with LV dyssynchrony. This
bility of CMR-TSI to almost totally discriminate between
atients with HF and healthy control subjects is perhaps a
eflection of the capacity of CMR to image the entire LV
ith superior spatial resolution.
Methods for assessing cardiac dyssynchrony using CMR
re emerging. Myocardial tagging, for example, allows
ssessment of wall motion and strain in circumferential,
adial, and longitudinal dimensions (18,19). Strain-coded
MR provides real-time quantitative strain measurement,
hich has the potential for rapid assessment of LV dyssyn-
hrony (18). Helm et al. (20) have recently developed a
ethod for assessing dyssynchrony using 3-dimensional
agged CMR. Velocity-encoded CMR has recently been
hown to have an excellent agreement with tissue Doppler
maging (21). By comparison, our measure of dyssynchrony,
MR-TSI, is comparatively crude, insofar as it is based
Figure 5 Kaplan-Meier Estimates of the Time to the Various Cl
Patients were stratified according to a pre-implant cardiovascular magnetic resona
Results of univariate Cox proportional hazards analyses are expressed in terms of
diovascular events.olely on radial motion. Notwithstanding, this relatively mimple measure provides powerful prognostic information in
atients undergoing CRT.
RS duration and mechanical dyssynchrony. Small
echanistic studies have shown that QRS duration correlated
ith LV dyssynchrony. Using a 12-segment model and tissue
oppler imaging, Yu et al. (17) failed to find a correlation
etween QRS duration and the LV dyssynchrony. We have,
owever, found that QRS duration does correlate strongly with
MR-TSI. This may be related to the high spatial resolution
f CMR. Notwithstanding, QRS duration failed to emerge as
predictor of clinical outcome measures when entered into
nalysis as either a continuous or a dichotomous (between 120
nd 149 ms or 150 ms) variable.
linical application. The interobserver and intraobserver
ariabilities for CMR-TSI of 9% compare favorably to
ther CMR measures of dyssynchrony, such as velocity-
ncoded CMR, for example, which is associated with
nterobserver and intraobserver variabilities of 10% (21).
ntraobserver and interobserver correlations for CMR-TSI
ere 0.99 and 0.98, respectively. Bader et al. (2) observed
ntraobserver and interobserver correlations of 0.99 and
.97, respectively, for an echocardiographic tissue Doppler
easure of dyssynchrony in 10 patients with HF. The
erivation of CMR-TSI is time-consuming, insofar as it
nvolves manual tracing of endocardial borders and deter-
End Points
sue synchronization imaging score (CMR-TSI) 110 ms or CMR-TSI 110 ms.
zard ratio (HR) and 95% confidence limits. HF  heart failure; MCE  major car-inical
nce tis
the haination of peak wall motion for each myocardial segment.
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Table 3 Univariate and Multivariate Cox Proportional Hazards Analysesof Clinical End Points in Relation to Cardiac Magnetic Resonance Variables
HR (95% CI) p Value
Death from any cause or hospitalization for MCE
Univariate
CMR-TSI 110 ms 2.49 (1.59 to 4.31) 0.0001
LVEDV 1.00 (1.00 to 1.01) 0.0621
LVESV 1.00 (1.00 to 1.01) 0.0459
LVEF 0.94 (0.91 to 0.99) 0.0115
QRS duration 1.00 (0.99 to 1.02) NS
Multivariate
1. CMR-TSI 110 ms 2.45 (1.51 to 4.34) 0.0002
LVEDV 1.00 (1.00 to 1.00) NS
2. CMR-TSI 110 ms 2.43 (1.29 to 4.33) 0.0002
LVESV 1.00 (1.00 to 1.00) NS
3. CMR-TSI 110 ms 2.28 (1.39 to 4.12) 0.0006
LVEF 0.98 (0.92 to 1.03) NS
Death from any cause or hospitalization for HF
Univariate
CMR-TSI 110 ms 2.21 (1.33 to 4.14) 0.0016
LVEDV 1.00 (1.00 to 1.01) NS
LVESV 1.00 (1.00 to 1.01) NS
LVEF 0.93 (0.88 to 0.98) 0.0064
QRS duration 1.00 (0.98 to 1.02) NS
Multivariate
1. CMR-TSI 110 ms 2.15 (1.23 to 4.14) 0.0060
LVEDV 1.00 (1.00 to 1.01) NS
2. CMR-TSI 110 ms 2.11 (1.20 to 4.07) 0.0083
LVESV 1.00 (1.00 to 1.01) NS
3. CMR-TSI 110 ms 1.82 (1.07 to 3.52) 0.0266
LVEF 0.95 (0.88 to 1.01) NS
Death from any cause
Univariate
CMR-TSI 110 ms 2.79 (1.45 to 7.06) 0.0011
LVEDV 1.00 (1.00 to 1.01) NS
LVESV 1.00 (1.00 to 1.01) NS
LVEF 0.93 (0.86 to 0.99) 0.0139
QRS duration 1.00 (0.98 to 1.02) NS
Multivariate
1. CMR-TSI 110 ms 2.60 (1.29 to 6.73) 0.0061
LVEDV 1.00 (1.00 to 1.01) NS
2. CMR-TSI 110 ms 2.55 (1.26 to 6.62) 0.0077
LVESV 1.00 (1.00 to 1.01) NS
3. CMR-TSI 110 ms 2.28 (1.16 to 5.90) 0.0143
LVEF 0.94 (0.86 to 1.02) NS
Cardiovascular death
Univariate
CMR-TSI 110 ms 4.1 (1.83 to 17.47) 0.0001
LVEDV 1.00 (1.00 to 1.00) 0.0487
LVESV 1.00 (1.00 to 1.01) 0.0368
LVEF 0.93 (0.86 to 0.99) 0.0183
QRS duration 1.01 (0.99 to 1.03) NS
Multivariate
1. CMR-TSI 110 ms 3.82 (1.63 to 16.5) 0.0007
LVEDV 1.00 (0.99 to 1.01) NS
2. CMR-TSI 110 ms 3.77 (1.61 to 16.3) 0.0009
LVESV 1.00 (0.99 to 1.01) NS
3. CMR-TSI 110 ms 3.49 (1.50 to 15.2) 0.0014
LVEF 0.96 (0.87 to 1.05) NSCI  confidence interval; HR  hazard ratio; other abbreviations as in Table 1.
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CRT and CMR July 17, 2007:243–52he technique, however, does not involve specialized acqui-
ition, as it employs the short-axis stacks of the LV normally
cquired during a standard CMR LV function study.
tudy limitations. One of the limitations of CMR relates
o its safety in patients with pacemakers, which may
reclude its use after implantation. Recent studies, however,
ave shown that CMR can be performed with safety in such
atients (22,23). These concerns are likely to wane with
mergence of CMR-compatible pacemakers. With respect
o the quantification of CMR-TSI, impaired LV contrac-
ion is associated with less variation in wall motion during
he cardiac cycle. Consequently, CMR-TSI may reflect
igher noise, or dyskinesis, rather than true dyssynchrony.
ur study of patients undergoing CRT is limited to patients
ith a QRS 120 ms. Our cutoff of 110 ms for CMR-TSI
s a predictor of mortality and events can, therefore, only be
pplied to a similar population, and not to patients with a
RS 120 ms, in whom this cutoff is likely to be lower. A
urther limitation is the lack of scar imaging. As demon-
trated by others (24–26), scar size as well as location are
lso powerful predictors of outcome after CRT and could,
onceivably, be superior to CMR-TSI.
onclusions
sing a novel CMR measure of LV dyssynchrony, CMR-TSI,
e have shown that HF is synonymous with intraventricular
yssynchrony. Importantly, CMR-TSI is a powerful indepen-
ent predictor of total mortality, cardiovascular mortality, and
ospitalizations for MCE and for HF after CRT. This
easure is, therefore, likely to be valuable in risk-stratifying
atients with ischemic cardiomyopathy before CRT.
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